St. Jude Looks to Natural Products Research for Children’s Cancer
Ingredients supplier ChromaDex will make its extensive ingredient library available to St. Jude for research.
St. Jude Children’s Research Hospital has forged a unique partnership with natural ingredients supplier ChromaDex (Irvine, CA) for children’s cancer research. ChromaDex will make its extensive ingredient library available to St. Jude, which will screen the library’s ingredients against biological assays and tumor models to identify ingredients that may have therapeutic promise-and that may be potentially patentable.
ChromaDex will also lend its expertise in natural products chemistry. St. Jude will perform further chemical assays to further characterize the natural compounds in the ChromaDex library.
“The ChromaDex catalog offers thousands of unique phytochemical compounds, many of which have never been investigated for their therapeutic potentials. We are excited to start this collaboration with St. Jude, as this program will not only allow ChromaDex to extract value from the natural products library, but also advance pediatric disease research,” said ChromaDex founder and CEO Frank Jaksch in a press release announcing the partnership.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.
